FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007098156> ?p ?o ?g. }

• W2007098156 abstract "The survival of patients with hematologic malignancies who require admission to the intensive care unit (I.C.U.) is poor. The potential for cure in this group of patients necessitates aggressive treatment that can result in life-threatening complications. A medical, ethical and financial dilemma arises when aggressive therapy and intensive support is balanced with actual survival, meaningful survival and the financial burden to society and the patient's family. We collected complete financial information on 64 leukemia and lymphoma patients admitted for the first time to the intensive care unit (I.C.U.) at the H. Lee Moffitt Cancer Center and Research Institute between 7/1/88 and 6/30/90. The charges were calculated from actual itemized statements and included all inpatient and out-patient charges. Survival was addressed by individually evaluating candidate variables with parametric and non-parametric analysis. Survival after I.C.U. admission and hospital discharge were studied as dependent variables in a stepwise multiple regression analysis. The nadir of the platelet count and albumin level prior to and during the I.C.U. admission significantly affected survival. During the I.C.U. admission, the BUN, serum creatinine and the need for mechanical ventilation significantly affected survival. Seventy-eight percent of patients survived less than five months and spent less than two and one half months at home. Fifty percent of patients expired during the I.C.U. admission. Only 3.2% of patients who had received two or more chemotherapeutic regimens had survived more than one year. The cost per year of life gained for the entire group of patients was $189,339. The results of this study show that the majority of leukemia and lymphoma patients who are admitted to the I.C.U. expire prior to discharge or spend a minimal amount of time at home prior to expiring. This study suggests that the cost of meaningful survival must be borne in mind by physicians and should encourage them to discuss treatment options, potential outcomes, risks and benefits so that a reasonable strategy can be planned by the physician, patient and family prior to treatment." @default.
• W2007098156 created "2016-06-24" @default.
• W2007098156 creator A5012920988 @default.
• W2007098156 creator A5019353746 @default.
• W2007098156 creator A5020157100 @default.
• W2007098156 creator A5029415334 @default.
• W2007098156 creator A5051174121 @default.
• W2007098156 creator A5065251770 @default.
• W2007098156 date "1993-11-01" @default.
• W2007098156 modified "2023-09-26" @default.
• W2007098156 title "HEROIC MEASURES WHEN TREATING PATIENTS WITH HEMATOLOGIC MALIGNANCIES - THE ECONOMIC COST OF SURVIVAL" @default.
• W2007098156 cites W1825853213 @default.
• W2007098156 cites W1991072987 @default.
• W2007098156 cites W1994733723 @default.
• W2007098156 cites W2004067714 @default.
• W2007098156 cites W2006211638 @default.
• W2007098156 cites W2014910738 @default.
• W2007098156 cites W2030679843 @default.
• W2007098156 cites W2034294525 @default.
• W2007098156 cites W2042373177 @default.
• W2007098156 cites W2079258373 @default.
• W2007098156 cites W2090635877 @default.
• W2007098156 cites W2092036984 @default.
• W2007098156 cites W2094421251 @default.
• W2007098156 cites W2095572782 @default.
• W2007098156 cites W2121879722 @default.
• W2007098156 cites W2164971443 @default.
• W2007098156 cites W2326110955 @default.
• W2007098156 cites W2411477783 @default.
• W2007098156 cites W1999065925 @default.
• W2007098156 doi "https://doi.org/10.3892/ijo.3.5.987" @default.
• W2007098156 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21573463" @default.
• W2007098156 hasPublicationYear "1993" @default.
• W2007098156 type Work @default.
• W2007098156 sameAs 2007098156 @default.
• W2007098156 citedByCount "1" @default.
• W2007098156 countsByYear W20070981562012 @default.
• W2007098156 crossrefType "journal-article" @default.
• W2007098156 hasAuthorship W2007098156A5012920988 @default.
• W2007098156 hasAuthorship W2007098156A5019353746 @default.
• W2007098156 hasAuthorship W2007098156A5020157100 @default.
• W2007098156 hasAuthorship W2007098156A5029415334 @default.
• W2007098156 hasAuthorship W2007098156A5051174121 @default.
• W2007098156 hasAuthorship W2007098156A5065251770 @default.
• W2007098156 hasConcept C10515644 @default.
• W2007098156 hasConcept C121608353 @default.
• W2007098156 hasConcept C126322002 @default.
• W2007098156 hasConcept C2776376669 @default.
• W2007098156 hasConcept C2780306776 @default.
• W2007098156 hasConcept C71924100 @default.
• W2007098156 hasConceptScore W2007098156C10515644 @default.
• W2007098156 hasConceptScore W2007098156C121608353 @default.
• W2007098156 hasConceptScore W2007098156C126322002 @default.
• W2007098156 hasConceptScore W2007098156C2776376669 @default.
• W2007098156 hasConceptScore W2007098156C2780306776 @default.
• W2007098156 hasConceptScore W2007098156C71924100 @default.
• W2007098156 hasLocation W20070981561 @default.
• W2007098156 hasLocation W20070981562 @default.
• W2007098156 hasOpenAccess W2007098156 @default.
• W2007098156 hasPrimaryLocation W20070981561 @default.
• W2007098156 hasRelatedWork W2048758530 @default.
• W2007098156 hasRelatedWork W2091020218 @default.
• W2007098156 hasRelatedWork W2325097216 @default.
• W2007098156 hasRelatedWork W2365364931 @default.
• W2007098156 hasRelatedWork W2418638721 @default.
• W2007098156 hasRelatedWork W2792975590 @default.
• W2007098156 hasRelatedWork W2899015171 @default.
• W2007098156 hasRelatedWork W2971392718 @default.
• W2007098156 hasRelatedWork W2983056940 @default.
• W2007098156 hasRelatedWork W3022091582 @default.
• W2007098156 isParatext "false" @default.
• W2007098156 isRetracted "false" @default.
• W2007098156 magId "2007098156" @default.
• W2007098156 workType "article" @default.